Cargando…
Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a serious threat to global health. SARS-CoV-2 infects host cells primarily by binding to angiotensin-converting enzyme 2, which is coexpressed in alveolar type 2 cells and gu...
Autores principales: | Xiang, Hui, Liu, Qi-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813939/ https://www.ncbi.nlm.nih.gov/pubmed/36620345 http://dx.doi.org/10.3748/wjg.v28.i47.6689 |
Ejemplares similares
-
Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?
por: Lau, Harry Cheuk-Hay, et al.
Publicado: (2022) -
Gut Microbiota Alteration and Its Modulation with Probiotics in Celiac Disease
por: Saviano, Angela, et al.
Publicado: (2023) -
The gut microbiota and its interactions with cardiovascular disease
por: Xu, Hui, et al.
Publicado: (2020) -
Sleep, circadian rhythm and gut microbiota: alterations in Alzheimer’s disease and their potential links in the pathogenesis
por: Li, Yi, et al.
Publicado: (2021) -
Therapeutic Potential of the Gut Microbiota in the Management of Sepsis
por: Bassetti, Matteo, et al.
Publicado: (2020)